Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

InnovAccer

Health Tech & Medtech · San Francisco, United States · Founded 2012 Unicorn

A Big data company that helps large healthcare organizations to adopt data driven healthcare operations

Valuation
$2.5–5B
Latest valuation · 2026
Unlock exact value
Revenue
$100–500M
Latest reported FY
Unlock exact value
Headcount
1–2k
Current team size
Unlock exact value

Investors

27 investors on InnovAccer's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 7 investors entered at this stage
Pankaj Jain
500 Global
Krishna Mehra
Arihant Patni
Rajan Anandan
Phanindra Sama
Nitin Singhal
Series A 5 investors entered at this stage
Series B+ 15 investors entered at this stage
Lightspeed Financial
Generation Investment Management
Dragoneer Investment Group
OMERS Private Equity
Kaiser Permanente
Danaher Ventures
Tiger Global
Whale Rock Capital Management
Mubadala Capital
Steadview Capital
Avidity Partners
M12
B Capital
Schonfeld Strategic Advisors
Banner Health

Ownership

Who owns InnovAccer

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

22.5% Founders

Some investors are hidden on this public profile. See the full cap table on Dealroom →

Global footprint

Where InnovAccer has talent and traffic

Workforce by country
15 countries with
team presence
🇮🇳 India80.6%
🇺🇸 United States17.6%
🇦🇪 United Arab Emirates0.6%
🇬🇧 United Kingdom0.2%
🇮🇪 Ireland0.2%
Top 5 of 15 shown
Web traffic by country
95K monthly visits
across markets
🇮🇳 India58.8%
🇺🇸 United States27.2%
🇦🇪 United Arab Emirates4.1%
🇨🇦 Canada1.9%
🇦🇺 Australia1.7%
Top 5 markets shown

Talent graph

The shape of InnovAccer's talent

Dealroom maps InnovAccer's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

9 standout operatorsDealroom-flagged across the org
14 AI specialistsincl. 1 core researchers
1,804 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock InnovAccer's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$506k patent portfolio · 12 active families

Estimated portfolio value
$506k
0.01% of valuation · 4.6× smaller than top peer Owkin ($2M)
12 active patent families
Where InnovAccer innovates Data scienceData setDatabaseMedical careNatural language

Where InnovAccer concentrates vs peers

Each axis is a top-10 topic across InnovAccer and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

InnovAccer's 4 investments and acquisitions.

Every disclosed deal where InnovAccer appeared as a backer or acquirer, 2024–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across InnovAccer's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where InnovAccer deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        InnovAccer's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about InnovAccer

        An AI-synthesized read of the highest-engagement posts about InnovAccer on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See InnovAccer on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.